O6 - Biomedical prevention for STIs and HIV

Moderator(s)

• MS

  Marc Steben
• 

  Sebastian Fuller, PhD (he/him/his)

  Senior postdoctoral social scientist - implementation science in global health
  University of Oxford

Presentations:

• 14:30 – 14:45 CST

  High uptake of Doxycycline for STI prevention (doxy-PEP) among individuals using HIV PrEP at a municipal sexual health clinic in San Francisco, California
  

  Primary Presenter: Oliver Bacon, MD MPH (he/him/his) – San Francisco City Clinic, San Francisco Department of Public Health
• 14:45 – 15:00 CST

  Syphilis testing, incidence, and reinfection among gay and bisexual men with and without HIV in Australia over a decade spanning HIV PrEP implementation
  

  Primary Presenter: Michael W. Traeger, PhD (he/him/his) – Burnet Institute
• 15:00 – 15:15 CST

  Self-reported adherence to event-driven doxycycline postexposure prophylaxis for sexually transmitted infection prevention among cisgender women
  

  Primary Presenter: Jenell Stewart, DO, MPH (she/her/hers) – Hennepin Healthcare Research Institute and University of Minnesota
• 15:15 – 15:30 CST

  A genomic perspective on the near-term impact of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae antimicrobial resistance
  

  Primary Presenter: Tatum D. Mortimer, PhD (she/her/hers) – Harvard T.H. Chan School of Public Health
• 15:30 – 15:45 CST

  Discontinuation of Pre-Exposure Prophylaxis and associated factors among Female Commercial Sex Workers attending the most at-risk population clinic, Mulago Hospital, Uganda
  

  Primary Presenter: Racheal Naturinda, Masters of Health Services Research – Makerere University School of Public Health
• 15:45 – 16:00 CST

  PrEP outcomes and sexual health in China during COVID-19 lockdowns
  

  Primary Presenter: Chunyan Li, PhD – Tokyo College, University of Tokyo; University of North Carolina Project China